ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,000.00
      -0.94%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      82.225
      -0.07%
      Bitcoin
      67,677.54
      -0.70%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Castle Biosciences Inc (CSTL) Quote

      Castle Biosciences Inc

      Castle Biosciences Inc (CSTL)

      NASDAQ
      19.92
      0.98
      (5.17%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      19.92
      0.00
      (0.00%)
      After Hours: 4:39PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      19.92
      Bid
      19.56
      Ask
      26.00
      Volume
      418,421
      18.70 Day's Range 20.23
      12.07 52 Week Range 25.91
      Market Cap
      522.88M
      Previous Close
      18.94
      Open
      18.87
      Last Trade
      1
      @
      20.24
      Last Trade Time
      Financial Volume
      $ 8,084,625
      VWAP
      19.3217
      Average Volume (3m)
      316,117
      Shares Outstanding
      27,607,183
      Dividend Yield
      -
      PE Ratio
      -9.57
      Earnings Per Share (EPS)
      -2.08
      Revenue
      219.79M
      Net Profit
      -57.47M

      About Castle Biosciences Inc

      Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more

      Sector
      Medical Laboratories
      Industry
      Medical Laboratories
      Website
      www.castlebiosciences.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Castle Biosciences Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CSTL. The last closing price for Castle Biosciences was $18.94. Over the last year, Castle Biosciences shares have traded in a share price range of $ 12.07 to $ 25.91.

      Castle Biosciences currently has 27,607,183 shares outstanding. The market capitalization of Castle Biosciences is $522.88 million. Castle Biosciences has a price to earnings ratio (PE ratio) of -9.57.

      CSTL Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      July 16 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      July 16 2024
      Edgar (US Regulatory)

      Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024

      Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second...

      July 15 2024
      Business Wire

      Castle Biosciences Honored with Top Workplaces Awards

      Castle earns recognition as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards Castle Biosciences, Inc. (Nasdaq:...

      July 11 2024
      Business Wire

      Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test

      Castle’s TissueCypher test has been shown to improve the risk stratification of patients with Barrett’s esophagus (BE)1,2 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health...

      June 24 2024
      Business Wire

      Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2024, the Compensation Committee of its...

      June 20 2024
      Business Wire

      Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner

      Maetzold selected as a winner of Ernst & Young’s prestigious annual awards among 48 visionary finalists in the Gulf South region, encompassing Central and South Texas, Louisiana and...

      June 14 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      June 04 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.995.2297939778118.9320.2318.2841549719.10677374CS
      4-1.13-5.3681710213821.0522.1816.96540554819.48580762CS
      120.381.9447287615119.5425.9116.96531611721.76361404CS
      260.160.8097165991919.7625.9116.96526914821.66427291CS
      522.9817.591499409716.9425.9112.0726828919.62823135CS
      156-44.06-68.86527039763.9878.5859.260128395925.68177306CS
      260-0.08-0.420107.699.260125438733.91725678CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SERVServe Robotics Inc
      $ 7.51
      (185.55%)
      		266.26M
      AUGXAugmedix Inc
      $ 2.27
      (147.71%)
      		24.14M
      XCURExicure Inc
      $ 0.5351
      (76.02%)
      		14.02M
      PSNLPersonalis Inc
      $ 3.83
      (56.33%)
      		22.8M
      MDBHMDB Capital Holdings LLC
      $ 10.675
      (37.21%)
      		126.45k
      SPWRSunPower Corporation
      $ 0.6735
      (-55.40%)
      		124.61M
      HYZNHyzon Motors Inc
      $ 0.149
      (-47.54%)
      		23.63M
      MEDSTRxADE Health Inc
      $ 14.92
      (-33.45%)
      		223.27k
      SILOSilo Pharma Inc
      $ 2.50
      (-27.95%)
      		11.93M
      KITTNauticus Robotics Inc
      $ 0.0935
      (-27.46%)
      		28.43M
      SERVServe Robotics Inc
      $ 7.51
      (185.55%)
      		266.26M
      SXTP60 Degrees Pharmaceuticals Inc
      $ 0.2602
      (5.77%)
      		226.82M
      NVDANVIDIA Corporation
      $ 117.93
      (-2.61%)
      		217.11M
      SQQQProShares UltraPro Short QQQ
      $ 8.46
      (2.79%)
      		188.2M
      SPWRSunPower Corporation
      $ 0.6735
      (-55.40%)
      		124.61M

      Discussion

      View Full Feed
      sylvia07 sylvia07 5 minutes ago
      Sad but true!
      GRST
      kabunushi kabunushi 9 minutes ago
      In any case imo the dude is off his rocker now, obsessively hating on people on this MB. Not at all the sign of a healthy individual dealing with whatever may have happened and moving on with his/her life as I would expect any normal person to. Whatever happened or didn't happen to him he's stuck in
      NWBO
      Louinjaxxx Louinjaxxx 10 minutes ago
      Technically always has been Pink Current Information....just a matter of syncing report filings. Only nervous nancies and bashers are concerned.
      AXXA
      sage4 sage4 12 minutes ago
      That makes total sense. A good strategic plan.
      AVXL
      sctts sctts 12 minutes ago
      $$$ Today is the Day $$$$

      $$$$ $frx $$$$
      FRX
      sage4 sage4 16 minutes ago
      Now you are talking
      AVXL
      flipper44 flipper44 32 minutes ago
      I played your post backwards and finally understood it.

      Sprechen sie geek?
      NWBO
      nowwhat2 nowwhat2 33 minutes ago
      Nite nite

      https://investorshub.advfn.com/uimage/uploads/2024/7/22/uhombBTC_777_21_6M_11PM_OHTL_RESIST_2021.jpg



      https://investorshub.advfn.com/uimage/uploads/2024/7/21/vromubtc_777_21_45d_8pm_w_666_10_1245_eth_etf.jpg



      BTCUSD
      Peeteman Peeteman 35 minutes ago
      Pink Current now from what I see?
      AXXA
      littlejohn littlejohn 39 minutes ago
      China central bank cuts rates by 10

      basis points today,

      after Biden dropped out of race and

      endorsed bad Karma...


      Two items may not be related other than

      timing to get ahead of potential fall out of

      U
      KILLAZILLA KILLAZILLA 40 minutes ago
      WRONG!!!
      https://www.wsj.com/video/kamala-harris-calls-out-joe-biden-over-racial-issues/DAA0D8FE-AF38-47A0-A8F6-E1B6E04B2BFC
      Real McCoy Real McCoy 41 minutes ago
      If it was actually confidential, no one including you would know.
      VeronicaFox VeronicaFox 46 minutes ago
      Past ”Shortcomings”??? lol, that’s like saying a 100 mile hike is just a little jog. Scozzafava has destroyed numerous companies and left those shareholders in financial ruin. He has one of the highest R/S rates in the OTC, and has diluted every company he ran - this one is sitting in trips. Here
      ALRN
      Bob Mullet Bob Mullet 47 minutes ago
      To da mooooooonn!!!!

      SOON??!?
      KBLB
      BDEZ BDEZ 48 minutes ago
      Kamala Harris body double?

      https://x.com/LauraLoomer/status/1815230918971265079
      BDEZ BDEZ 54 minutes ago
      A new party, called the American Commie Party

      https://x.com/MJTruthUltra/status/1815203197973057755
      KILLAZILLA KILLAZILLA 56 minutes ago
      GARBAGE!!!!

      TDS AFFECTED SCUM!!!!!!!
      Jason2931 Jason2931 59 minutes ago
      Thank you
      GDVM
      BDEZ BDEZ 59 minutes ago
      Trump Hires Private Security As Pentagon Confirms Deep State Plot Against 45

      https://x.com/RealAlexJones/status/1815224689725178345
      midastouch017 midastouch017 59 minutes ago
      What appeals to them is not only NexoBrid which is a complimentary
      product to theirs, but EscharEx® the bioactive, multimodal debridement
      therapy for the treatment of chronic and other hard-to-heal wounds.

      In other words, Mölnlycke is buying into a potential product wh
      MDWD
      cootcat cootcat 1 hour ago
      Starting to sound Questionable now. Will it happen?
      ILUS
      theswordman theswordman 1 hour ago
      BNO News @BNOFeed
      Weekly U.S. COVID update:

      - New cases: 130,895 est.
      - Average: 107,857 (+12,608)
      - In hospital: 3,583 (+663)
      - In ICU: 367 (+79)
      - New deaths: 552
      - Average: 493 (+23)

      BNO Analysis: So far this year, nearly 4 m
      TOMDF
      skitahoe skitahoe 1 hour ago
      Dmb, it may be politics, but frankly I believe the regulators are hearing from the not only the politicians, but also the public, to reduce the cost of developing drugs. I believe the streamlining the regulators are doing is a good start, but frankly they have a long way to go.

      I bel
      NWBO
      Heisgreater Heisgreater 1 hour ago
      Very interesting post Silk. DS has such huge application possibilities. It's always exciting to hear about new ones. Hope to hear many more applications from posters like you. Keep it up 👍
      GO KBLB!!
      KBLB

      Your Recent History

      NASDAQ
      CSTL
      Castle Biosciences
      NYSE
      BFK
      BlackRock Municipal Income
      Delayed Upgrade Clock